A multidimensional assessment of payback: Evaluating the impact of Breast Cancer Trials.
Ruth KnightBelinda LukeRenata MeuterKaitlin PetersKathleen ChellPublished in: Asia-Pacific journal of clinical oncology (2024)
BCT's clinical trials have had a significant impact on the prevention, detection, treatment, and management of breast cancer. Measuring and reporting impact can be resource intensive but support BCT in remaining accountable to all those invested in the organization and in breast cancer clinical trials, evidencing the multiple dimensions of payback resulting from the organization's research.